Princeton, NJ. June 2023:Delphine Diagnostics, a pioneering figure in advanced medical diagnostics, proudly showcased its commitment to scientific collaboration and innovation at the recently concluded New Jersey Research Cores Partnering Conference held this June. The conference brought together leading minds and emerging talents from across the state, with Delphine’s Founder, Andy Bala, and a team comprising Student Interns Isis Gonzalez and Iram Contractor spearheading the company’s representation.
With a focus on nurturing partnerships and igniting transformative ideas, this event was a significant step toward fostering a vibrant scientific community within the region. Delphine Diagnostics seized this occasion to not only share its groundbreaking work but also to establish enduring connections that promise to enrich the scientific landscape.
A notable highlight of the conference was Mr. Bala’s participation as a distinguished panelist. As one of the select Life Sciences startup Eco System Founders from New Jersey, he lent his insights to a discussion centered around the Success Stories of the CSIT Voucher Program. Delphine’s engagement with this program has been pivotal in advancing its cutting-edge research, particularly in enhanced diagnostics, benefitting patients across the global healthcare spectrum.
Delphine Diagnostics expressed its gratitude towards the New Jersey Commission on Science Innovation and Technology Organization (NJ CSIT) for providing this invaluable platform. The exposure garnered from the conference has not only underscored Delphine’s dedication to elevating healthcare standards but has also paved the way for the forthcoming launch of a groundbreaking product – the Sepsis Diagnostics Assay. This revolutionary assay holds the potential to redefine the standard of care for sepsis patients, offering a lifeline that could save countless lives and shield those at risk from this formidable condition.
As Delphine Diagnostics continues to push the boundaries of medical diagnostics, its participation in the NJ Cores Partnering Conference stands as a testament to the company’s unwavering commitment to collaboration, innovation, and ultimately, to the betterment of global healthcare outcomes.
Great news!
Delphine is thrilled to announce that our brilliant Scientist, Dr. Mary Stack, has recently been awarded a grant from the prestigious New Jersey Innovation and Research Fellowship Program. This remarkable achievement brings a wave of excitement to our entire team!
The Innovation and Research Fellowship Program (IRFP) grant serves as a beacon of support for technological research and the thriving innovation ecosystem in New Jersey. With this grant, Delphine aims to revolutionize the field of diagnostic testing with our highly anticipated Sepsis Diagnostic Assay.
Sepsis, a severe and life-threatening condition, demands prompt detection and treatment. However, the current gold standard of blood culture can take up to a painstaking 72 hours to provide results. But fear not! Delphine’s innovative Sepsis Diagnostic Assay seeks to dramatically reduce the time-to-diagnosis to a mere 4 hours, comparable to the swift pace of nucleic acid amplification.
At Delphine Diagnostics, our unwavering focus revolves around identifying and commercializing advancements in diagnostic testing. We wholeheartedly believe that accurate and speedy diagnoses play a vital role in combatting infectious diseases. By improving the accuracy and efficiency of diagnostic tests, we strive to make a significant impact on public health and well-being.
We are bursting with joy and pride as we embark on this groundbreaking journey alongside Dr. Mary Stack. Her dedication and expertise are invaluable assets to our team, and we are confident that her groundbreaking research will pave the way for a brighter future in the field of sepsis diagnosis.
Stay tuned for more updates as we work tirelessly to bring this revolutionary Sepsis Diagnostic Assay to the forefront of medical advancements. Together, let’s shape a world where rapid and accurate diagnostic testing saves lives and brings hope to those in need!
Cheers,
The Delphine Diagnostics Team